A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

To improve prognosis in recurrent glioblastoma we developed a treatment protocol based on a combination of drugs not traditionally thought of as cytotoxic chemotherapy agents but that have a robust history of being well-tolerated and are already marketed and used for other non-cancer indications. Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kast, Richard E., Boockvar, John A., Brüning, Ansgar, Cappello, Francesco, Chang, Wen-Wei, Cvek, Boris, Dou, Q. Ping, Duenas-Gonzalez, Alfonso, Efferth, Thomas, Focosi, Daniele, Ghaffari, Seyed H., Karpel-Massler, Georg, Ketola, Kirsi, Khoshnevisan, Alireza, Keizman, Daniel, Magné, Nicolas, Marosi, Christine, McDonald, Kerrie, Muñoz, Miguel, Paranjpe, Ameya, Pourgholami, Mohammad H., Sardi, Iacopo, Sella, Avishay, Srivenugopal, Kalkunte S., Tuccori, Marco, Wang, Weiguang, Wirtz, Christian R., Halatsch, Marc-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720600/
https://www.ncbi.nlm.nih.gov/pubmed/23594434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720600/
https://www.ncbi.nlm.nih.gov/pubmed/23594434

Ejemplares similares